Brokerages expect National Vision Holdings Inc (NASDAQ:EYE) to report $0.12 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Three analysts have issued estimates for National Vision’s earnings, with the highest EPS estimate coming in at $0.13 and the lowest estimate coming in at $0.10. National Vision also reported earnings of $0.12 per share during the same quarter last year. The business is scheduled to report its next quarterly earnings report on Tuesday, November 12th.
According to Zacks, analysts expect that National Vision will report full-year earnings of $0.68 per share for the current fiscal year, with EPS estimates ranging from $0.66 to $0.69. For the next fiscal year, analysts forecast that the business will report earnings of $0.78 per share, with EPS estimates ranging from $0.72 to $0.81. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side research analysts that that provide coverage for National Vision.
National Vision (NASDAQ:EYE) last released its quarterly earnings results on Tuesday, August 6th. The company reported $0.20 EPS for the quarter, missing the consensus estimate of $0.21 by ($0.01). The firm had revenue of $429.50 million for the quarter, compared to analyst estimates of $423.27 million. National Vision had a return on equity of 6.30% and a net margin of 0.92%. The company’s quarterly revenue was up 11.4% on a year-over-year basis. During the same period last year, the firm earned $0.21 EPS.
In related news, SVP John Vaught sold 48,611 shares of National Vision stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $30.11, for a total value of $1,463,677.21. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, major shareholder Vision Aggregator L.P. Kkr sold 9,149,908 shares of National Vision stock in a transaction that occurred on Monday, August 12th. The shares were sold at an average price of $30.52, for a total value of $279,255,192.16. The disclosure for this sale can be found here. Company insiders own 2.60% of the company’s stock.
Several institutional investors have recently bought and sold shares of EYE. Strs Ohio purchased a new stake in shares of National Vision in the second quarter valued at approximately $46,000. Aperio Group LLC purchased a new stake in shares of National Vision in the second quarter valued at approximately $59,000. Tower Research Capital LLC TRC purchased a new stake in shares of National Vision in the second quarter valued at approximately $75,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of National Vision by 32.4% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 4,837 shares of the company’s stock valued at $116,000 after buying an additional 1,184 shares in the last quarter. Finally, Panagora Asset Management Inc. purchased a new stake in shares of National Vision in the second quarter valued at approximately $201,000.
EYE traded up $0.31 during trading on Wednesday, hitting $23.63. 430,392 shares of the stock were exchanged, compared to its average volume of 847,187. The firm has a market capitalization of $1.82 billion, a P/E ratio of 52.51, a PEG ratio of 2.46 and a beta of 1.44. National Vision has a 1-year low of $22.02 and a 1-year high of $45.88. The stock has a fifty day moving average price of $25.39 and a two-hundred day moving average price of $28.24. The company has a quick ratio of 0.57, a current ratio of 0.94 and a debt-to-equity ratio of 1.16.
About National Vision
National Vision Holdings, Inc, through its subsidiaries, operates as an optical retailer primarily in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products, as well as eye exams through its America's Best, Eyeglass World, Vista Optical, and Vista Optical Military, as well as Vision Center brand stores; and provides health maintenance organization, vision care benefit plan, and optometric services.
Featured Story: Systematic Risk
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for National Vision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Vision and related companies with MarketBeat.com's FREE daily email newsletter.